SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-013504
Filing Date
2024-04-29
Accepted
2024-04-29 08:18:55
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A urgn20231231_10ka.htm   iXBRL 10-K/A 433868
2 EXHIBIT 31.3 ex_653285.htm EX-31.3 4238
3 EXHIBIT 31.4 ex_653286.htm EX-31.4 4243
8 actualceodirectcompensat.jpg GRAPHIC 25632
  Complete submission text file 0001437749-24-013504.txt   774971

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20231231.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20231231_def.xml EX-101.DEF 17405
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20231231_lab.xml EX-101.LAB 23725
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20231231_pre.xml EX-101.PRE 18445
20 EXTRACTED XBRL INSTANCE DOCUMENT urgn20231231_10ka_htm.xml XML 7442
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38079 | Film No.: 24886709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)